182 related articles for article (PubMed ID: 35040418)
1. Design, Synthesis and Evaluation of Novel (E)-N'-((1-(4-chlorobenzyl)-1H-indol-3-yl)methylene)-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides as Antitumor Agents.
Dung DTM; Park EJ; Anh DT; Hai PT; Bao LQ; Ji AY; Kang JS; Tung TT; Han SB; Nam NH
Anticancer Agents Med Chem; 2022; 22(14):2586-2598. PubMed ID: 35040418
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and evaluation of novel (E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides as antitumor agents.
Dung DTM; Park EJ; Anh DT; Hai PT; Huy LD; Jun HW; Kwon JH; Young Ji A; Kang JS; Tung TT; Dung PTP; Han SB; Nam NH
Arch Pharm (Weinheim); 2022 Jan; 355(1):e2100216. PubMed ID: 34674294
[TBL] [Abstract][Full Text] [Related]
3. Novel 3,4-dihydro-4-oxoquinazoline-based acetohydrazides: Design, synthesis and evaluation of antitumor cytotoxicity and caspase activation activity.
Huan LC; Tran PT; Phuong CV; Duc PH; Anh DT; Hai PT; Huong LTT; Thuan NT; Lee HJ; Park EJ; Kang JS; Linh NP; Hieu TT; Oanh DTK; Han SB; Nam NH
Bioorg Chem; 2019 Nov; 92():103202. PubMed ID: 31479984
[TBL] [Abstract][Full Text] [Related]
4. (E)-N'-Arylidene-2-(4-oxoquinazolin-4(3H)-yl) acetohydrazides: Synthesis and evaluation of antitumor cytotoxicity and caspase activation activity.
Huan LC; Phuong CV; Truc LC; Thanh VN; Pham-The H; Huong LT; Thuan NT; Park EJ; Ji AY; Kang JS; Han SB; Tran PT; Nam NH
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):465-478. PubMed ID: 30734614
[TBL] [Abstract][Full Text] [Related]
5. New Acetohydrazides Incorporating 2-Oxoindoline and 4-Oxoquinazoline: Synthesis and Evaluation of Cytotoxicity and Caspase Activation Activity.
Huan LC; Anh DT; Truong BX; Duc PH; Hai PT; Duc-Anh L; Huong LT; Park EJ; Lee HJ; Kang JS; Tran PT; Thanh Hai DT; Kim Oanh DT; Han SB; Nam NH
Chem Biodivers; 2020 Mar; 17(3):e1900670. PubMed ID: 31943757
[TBL] [Abstract][Full Text] [Related]
6. N'-[(E)-Arylidene]-2-(2,3-dihydro-3-oxo-4H-1,4-benzoxazin-4-yl)-acetohydrazides: Synthesis and Evaluation of Caspase Activation Activity and Cytotoxicity.
Huan LC; Truc LC; Phuong CV; Hai PT; Huong LT; Linh NTP; Thuan NT; Park EJ; Choi YJ; Kang JS; Han SB; Nam NH; Tran PT
Chem Biodivers; 2018 Oct; 15(10):e1800322. PubMed ID: 30054973
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of novel
Huan LC; Anh DT; Hai PT; Anh LD; Park EJ; Ji AY; Kang JS; Dung DTM; Oanh DTK; Tung TT; Hai DTT; Han SB; Nam NH
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1854-1865. PubMed ID: 32981382
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of novel 2-oxoindoline-based acetohydrazides as antitumor agents.
Dung DTM; Park EJ; Anh DT; Phan DTP; Na IH; Kwon JH; Kang JS; Tung TT; Han SB; Nam NH
Sci Rep; 2022 Feb; 12(1):2886. PubMed ID: 35190616
[TBL] [Abstract][Full Text] [Related]
9. Quinazolin-4(3H)-one-Based Hydroxamic Acids: Design, Synthesis and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity.
Hieu DT; Anh DT; Hai PT; Thuan NT; Huong LT; Park EJ; Young Ji A; Soon Kang J; Phuong Dung PT; Han SB; Nam NH
Chem Biodivers; 2019 Apr; 16(4):e1800502. PubMed ID: 30653817
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, pharmacological screening and computational analysis of some 2-(1H-Indol-3-yl)-N'-[(un)substituted phenylmethylidene] acetohydrazides and 2-(1H-Indol-3-yl)-N'-[(un)substituted benzoyl/2-thienylcarbonyl]acetohydrazides.
Rubab K; Abbasi MA; Rehman A; Siddiqui SZ; Shah SAA; Ashraf M; Ain Q; Ahmad I; Lodhi MA; Ghufran M; Shahid M; Fatima H
Pak J Pharm Sci; 2017 Jul; 30(4):1263-1274. PubMed ID: 29039324
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis and Bioevaluation of Two Series of 3-[(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]quinazolin-4(3H)-ones and N-(1-Benzylpiperidin-4-yl)quinazolin-4-amines.
Lan TT; Anh DT; Pham-The H; Dung DTM; Park EJ; Jang SD; Kwon JH; Kang JS; Thuan NT; Han SB; Nam NH
Chem Biodivers; 2020 Jul; 17(7):e2000290. PubMed ID: 32356584
[TBL] [Abstract][Full Text] [Related]
12. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
14. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
16. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.
Sever B; Altıntop MD; Çiftçi GA; Özdemir A
Med Chem; 2021; 17(10):1104-1128. PubMed ID: 33087032
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel isatin-based derivatives targeting cell cycle checkpoint pathways as potential anticancer agents.
Yousef MA; Ali AM; El-Sayed WM; Qayed WS; Farag HHA; Aboul-Fadl T
Bioorg Chem; 2020 Dec; 105():104366. PubMed ID: 33212312
[TBL] [Abstract][Full Text] [Related]
18. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
Kassab AE; Hassan RA
Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
[TBL] [Abstract][Full Text] [Related]
19. Novel (E)-3-(3-Oxo-4-substituted-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-N-hydroxypropenamides as Histone Deacetylase Inhibitors: Design, Synthesis and Bioevaluation.
Minh Sang D; Ho Na I; Tien Anh D; Thi Mai Dung D; Thi Thu Hang N; Phuong-Anh NT; Hai PT; Thi Kim Oanh D; Thanh Tung T; Jung Lee S; Hee Kwon J; Soon Kang J; Han SB; Thi Thanh Hai D; Nam NH
Chem Biodivers; 2023 May; 20(5):e202201030. PubMed ID: 37017259
[TBL] [Abstract][Full Text] [Related]
20. Development of certain aminoquinazoline scaffolds as potential multitarget anticancer agents with apoptotic and anti-proliferative effects: Design, synthesis and biological evaluation.
Amin NH; El-Saadi MT; Abdel-Fattah MM; Mohammed AA; Said EG
Bioorg Chem; 2023 Jun; 135():106496. PubMed ID: 36989735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
